NMBDs Flashcards

1
Q

Pancuronium

Aminosteroid

A

0.08-0.12mg/kg intubation
0.01mg/kg maintenance
Onset: 3-5 minutes
Duration: 60-90 minutes
CV Effects: increase HR, MAP and COP
Clearance: Renal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Atracurium

Benzylisoquinolinium

A

0.5 mg/kg
Onset: 3-5 minutes
Duration: 20-35 minutes
Clearance: Hoffman, ester hydrolysis, pH dependent
Side Effects: Histamine release, CV
Clinical Considerations: pH and temperature
Faster pediatric block
Longer lasting on elderly
Laudanosine CNS stimulant metabolite cleared by the kidney.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cisatracurium

Benzylisoquinolinium

A
0.1-0.15mg/kg
Infusion: 1-2mcg/kg/min
Onset:3-5 minutes
Duration: 20-35 minutes
Histamine RElease
Metabolism: Hoffman degredation
- time, temp, pH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Vecuronium

Aminosteroid

A

0.08-0.12mg/kg
0.01 mg/kg q 15-20 minutes
1-2mcg/kg/min
Clearance: Renal and hepatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rocuronium

Aminosteroid

A
0.6-1.2mg/kg
5-12mcg/kg/min
0.1mg/kg maintenance
Onset: similar to sux
Duration: 20-30 minutes
Clearance: Renal, no metabolism
Effects: no histamine release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mivacurium

Benzylisoquinolinium

A

0.15-0.2 mg/kg
4-10mcg/kg/min
Duration: Increased with atypical cholinesterase
Clearance: Plasma cholinesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Renal Failure Options

A

Mivacurium
Cisatracurium
Atracurium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Long Case Option

A

Pancuronium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pseudocholinesterase Deficient

A

Rocuronium

Vecuronium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Succinylcholine

A
Attaches to alpha subunit of nicotinic
Dose: 1-2 mg/kg
Onset: 30-60s
Duration: 3-5 min
Metabolism: Plasma cholinesterases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Neostigmine

Anticholinesterase

A
Dose: 0.04-0.07 mg/kg
Onset: 5-10 minutes
Peak: 10 minutes
Duration: 1 hour
Excessive doses can prolong block
Max dose is not 5 mg
Potentiates sux phase 1 block
Cause PONV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Edrophonium

Anticholinesterase

A

0.5 mg/kg

Fast reversal but doesn’t last long enough ~1hr. Some relaxants could overcome towards the end.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pyridostigmine

Anticholinesterase

A

0.21mg/kg
Slower onset than neostigmine
Lasts over 2 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Anticholinergics

A

Prevent Ach from binding to muscarinc receptors
Reversible bond to receptor
Can be overcome with increased Ach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Anticholinergic Effects

A
Sedation (IM scopolamine)
Antisialagogue
Heart Rate
Relax Smooth Muscle
Mydriasis
Prevention of Motion Sickness
Decrease Gastric Secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Atropine Effects

A
Minimal sedation
Minimal antisialogogue
Maximum increased HR
Moderate smooth muscle relax
Minimal mydriasis
Minimal PONV prevention
Minimal GI reduction
17
Q

Scopolamine Effects

A
Maximum sedation
Maximum antisialogogue
Minimum increased HR
Minimum smooth muscle relax
Maximum mydriasis
Maximum PONV prevention
Minimal GI reduction
18
Q

Glycopyrrolate Effects

A
No sedation
Moderate antisialogogue
Moderate increased HR
Moderate smooth muscle relax
No mydriasis
No PONV prevention
Minimal GI reduction
19
Q

Pre-med Sedation

A

Scopolamine is the most potent
Works at reticular activating system
Causes amnesia
Patients can go the other way and get restless

20
Q

Pre-med antisialogogue

A
Scopolamine most potent
3x more potent than atropine
Glycopyrrolate
2x more potent than atropine
Used when sedation undesired
21
Q

Pre-med treat bradycardia

A

Blocks ach @ SA node

Glyco=atropine in effectiveness

22
Q

Bronchodilation

A

Mechanism
Muscarinic receptors
Smooth muscle of medium/large A/W
Decrease resistance and increase deadspace
Ipratropium: Combivent (albuterol and ipratropium)

23
Q

Other uses

A

Biliary/ureteral relaxation
Mydriasis/cycloplegia
Gastric Acid Cessation
Motion induced N/V prevention

24
Q

Central Anticholinergic Syndrome

A

Symptoms: Restlessness/hallucinations
Somnolence/unconsciousness
Treatment: Physostigmine - crosses BBB
Who: Children and elderly

25
Q

Anticholinergic OD

A

Rapid onset: Dry mouth, blurred vision, tachycardia, increased temp, flushing, irritability.
Effect: Seizures, coma, ventilatory paralysis
Treatment: Physostigmine

26
Q

Reversal Criteria (sort of)

A
TOF >0.7
Tetanus with 100Hz
Grip strength
Negative inspiratory pressure >20cmH2O
Sustained head lift = 5s
27
Q

Sugammadex

A
New frontier in NDNMD reversal
Independent of Ach level
No twitches can be reversed
Cleared renally
No need for muscarinic antagonist
Some evidence of anaphylactic reaction